Beringea exits life sciences company Altacor
Beringea’s portfolio company Altacor has been acquired by Esperante, a Netherlands-based life science investment company, for an undisclosed sum. Beringea first invested in Altacor in 2007. Altacor is a specialty ophthalmology company with a portfolio of eight marketed pharmaceutical products. The company differentiates its development products primarily through formulation
